Named as a key player in 33 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Insulin Delivery Devices | Medical Devices | $15.9 Bn | 6.5% |
Named as key players in the same markets as Wockhardt Ltd. (number of shared markets).
Eli Lilly and Company1 shared market
Medtronic1 shared market
Novo Nordisk A/S1 shared market
Sanofi1 shared market